1. Interaction in the recognition of endothelin-1 (ET-1), a typical bivalent ET receptor-ligand, between ET
A and ET
B receptors was investigated in the rat anterior pituitary gland, using our quantitative receptor autoradiographic method with tissue sections preserving the cell-membrane structure and ET receptor-related compounds.2. In saturation binding studies with increasing concentrations (0.77–200 pM) of
125I-ET-1 (nonselective bivalent radioligand),
125I-ET-1 binding to the rat anterior pituitary gland was saturable and single with a
K
D of 71 pM and a
B
max of 120 fmol mg
–1. When 1.0 M BQ-123 (ET
A antagonist) was added to the incubation buffer, binding parameters were 8.3 pM of
K
D and 8.0 fmol mg
–1 of
B
max, whereas 10 nM sarafotoxin S6c (ET
B agonist) exerted little change in these binding parameters (
K
D, 72 pM;
B
max, 110 fmol mg
–1).3. Competition binding studies with a fixed amount (3.8 pM) of
125I-ET-1 revealed that when 1.0 M BQ-123 was present in the incubation buffer, ET
B receptor-related compounds such as sarafotoxin S6c, ET-3, IRL1620 (ET
B agonist), and BQ-788 (ET
B antagonist) competitively inhibited
125I-ET-1 binding with
K
is of 140, 18, 350 pM, and 14 nM, respectively, however, these compounds were not significant competitors for
125I-ET-1 binding in the case of absence of BQ-123.4. In cold-ligand saturation studies with a fixed amount (390 pM) of
125I-IRL 1620 (ET
B radioligand), IRL1620 bound to a single population of the ET
B receptor, and no change was observed in binding characteristics in the presence of 1.0 M BQ-123.
125I-IRL1620 binding was competitively inhibited by ET-1 and ET-3 in the absence of BQ-123, with
K
is of 20 and 29 pM, respectively, the affinities being much the same as those of 29 nM, in the presence of 1.0 M BQ-123.5. Two nonbivalent ET
A antagonists, BQ-123 and PD151242, were highly sensitive and full competitors for
125I-ET-1 binding (5.0 pM), in the presence of 10 nM sarafotoxin S6c.6. Taken together with the present finding that mRNAs encoding the rat ET
A and the ET
B receptors are expressed in the anterior pituitary gland, we tentatively conclude that although there are ET
A and ET
B receptors with a functional binding capability for ET receptor-ligands, the ET
B receptor does not independently recognize ET-1 without the aid of the ET
A receptor. If this thesis is tenable, then ET-1 can bridge between the two receptors to form an ET
A–ET
B receptor heterodimer.
相似文献